Cutaneous leishmaniasis: Treatment with ketoconazole

L. Weinrauch, R. Livshin, J. El On

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


A 17-year-old boy with an eight-month history of cutaneous leishmaniasis on the left earlobe was treated with ketoconazole for a period of four weeks. The patient showed excellent improvement both clinically and protozoologically. Ketoconazole, a new imidazole bound covalently to piperazine, has been developed as a broad spectrum antimycotic agent and appears to be a good antileishmanial drug.

Original languageEnglish
Pages (from-to)288-289+294
Issue number3
StatePublished - 1 Jan 1983
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Cutaneous leishmaniasis: Treatment with ketoconazole'. Together they form a unique fingerprint.

Cite this